These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 39050978)
21. Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol. Verkerk K; Geurts BS; Zeverijn LJ; van der Noort V; Verheul HMW; Haanen JBAG; van der Veldt AAM; Eskens FALM; Aarts MJB; van Herpen CML; Jalving M; Gietema JA; Devriese LA; Labots M; Barjesteh van Waalwijk van Doorn-Khosrovani S; Smit EF; Bloemendal HJ Lancet Reg Health Eur; 2024 Apr; 39():100875. PubMed ID: 38464480 [TBL] [Abstract][Full Text] [Related]
22. Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study. Waterhouse D; Iadeluca L; Sura S; Wilner K; Emir B; Krulewicz S; Espirito J; Bartolome L Target Oncol; 2022 Jan; 17(1):25-33. PubMed ID: 34964940 [TBL] [Abstract][Full Text] [Related]
23. First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from Israel. Averbuch I; Salman S; Shtamper N; Doweck I; Popovtzer A; Markel G; Hendler D; Finkel I; Moore A; Fenig E; Taha T; Mhameed K; Kurman N; Billan S Front Oncol; 2023; 13():1117804. PubMed ID: 36793605 [TBL] [Abstract][Full Text] [Related]
24. Previous radiotherapy increases the efficacy of cemiplimab in the treatment of locally advanced and metastatic cutaneous squamous cell carcinoma: A retrospective analysis. Nardone V; Napolitano S; Gagliardi F; Esposito A; Caraglia F; Briatico G; Scharf C; Ronchi A; D'Onofrio I; D'Ippolito E; Russo A; Belfiore MP; Franco R; Argenziano G; Ciardiello F; Reginelli A; Cappabianca S; Troiani T J Am Acad Dermatol; 2024 Oct; 91(4):678-683. PubMed ID: 38885840 [TBL] [Abstract][Full Text] [Related]
25. PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell Carcinoma. Yakobson A; Abu Jama A; Abu Saleh O; Michlin R; Shalata W Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627069 [TBL] [Abstract][Full Text] [Related]
26. Real world safety outcomes using cemiplimab for cutaneous squamous cell carcinoma. Valentin J; Gérard E; Ferte T; Prey S; Dousset L; Dutriaux C; Beylot-Barry M; Pham-Ledard A J Geriatr Oncol; 2021 Sep; 12(7):1110-1113. PubMed ID: 33736973 [TBL] [Abstract][Full Text] [Related]
27. Real-world outcomes of systemic therapy in locally advanced, recurrent or metastatic cutaneous squamous cell carcinoma. Vo TT; Espirito JL; Boyd M; Gumuscu B; Chirovsky D; Robert NJ; Swaby RF; Zhou W; Cowey CL Future Oncol; 2022 Jun; 18(17):2087-2099. PubMed ID: 35240857 [TBL] [Abstract][Full Text] [Related]
30. Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial. Sezer A; Kilickap S; Gümüş M; Bondarenko I; Özgüroğlu M; Gogishvili M; Turk HM; Cicin I; Bentsion D; Gladkov O; Clingan P; Sriuranpong V; Rizvi N; Gao B; Li S; Lee S; McGuire K; Chen CI; Makharadze T; Paydas S; Nechaeva M; Seebach F; Weinreich DM; Yancopoulos GD; Gullo G; Lowy I; Rietschel P Lancet; 2021 Feb; 397(10274):592-604. PubMed ID: 33581821 [TBL] [Abstract][Full Text] [Related]
31. CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma. Migden MR; Chandra S; Rabinowits G; Chen CI; Desai J; Seluzhytsky A; Sasane M; Campanelli B; Chen Z; Freeman ML; Ibrahim SF; Khushalani NI; Andria M; Ruiz E Future Oncol; 2020 Feb; 16(4):11-19. PubMed ID: 31951149 [TBL] [Abstract][Full Text] [Related]
32. Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck. Harris BN; Pipkorn P; Nguyen KNB; Jackson RS; Rao S; Moore MG; Farwell DG; Bewley AF JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):153-158. PubMed ID: 30570645 [TBL] [Abstract][Full Text] [Related]
33. Real-world study of patients with locally advanced HNSCC in the community oncology setting. Black CM; Ramakrishnan K; Nadler E; Tseng WY; Wentworth C; Murphy J; Fulcher N; Wang L; Alexander M; Patton G Front Oncol; 2023; 13():1155893. PubMed ID: 37664029 [TBL] [Abstract][Full Text] [Related]
34. Promising Immune Treatment of Advanced Cutaneous Squamous Cell Carcinoma with Cemiplimab-Real-World Experience in the Global SARS-CoV-2 Pandemic. Pabianek M; Lesiak A; Nejc D; Kuncman Ł; Narbutt J; Skibińska M; Ciążyńska M Curr Oncol; 2022 Oct; 29(10):7794-7801. PubMed ID: 36290893 [TBL] [Abstract][Full Text] [Related]